Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:biosimilar |
| gptkbp:activeIngredient |
gptkb:pegfilgrastim
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L03AA13
|
| gptkbp:brand |
Udenyca
|
| gptkbp:drugClass |
colony stimulating factor
|
| gptkbp:form |
injection
prefilled syringe |
| gptkbp:indication |
reduce infection risk in patients with non-myeloid cancer receiving myelosuppressive chemotherapy
|
| gptkbp:manufacturer |
gptkb:Coherus_BioSciences
|
| gptkbp:mechanismOfAction |
stimulates production of neutrophils
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:product |
gptkb:Neulasta
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:UDENYCA
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
pegfilgrastim-cbqv
|